Literature DB >> 19656969

Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections.

Kwonil Jung1, Gourapura J Renukaradhya1, Konstantin P Alekseev1, Ying Fang2, Yuxin Tang1, Linda J Saif1.   

Abstract

The innate immune response is critical for host defence against respiratory coronaviruses (CoVs). This study demonstrated that an ongoing respiratory virus infection compromises innate immune responses and affects the pathogenesis of a respiratory CoV co-infection. An innate immunosuppressive respiratory virus infection was established by infecting weaned pigs with porcine reproductive and respiratory syndrome virus (PRRSV); 10 days later, the pigs were exposed to porcine respiratory coronavirus (PRCV). The PRRSV/PRCV dual-infected pigs had reduced weight gains, a higher incidence of fever and more severe pneumonia compared with either single infection. Significant suppression of innate immune responses [reduced alpha interferon (IFN-alpha) levels in the lungs and reduced blood natural killer cell cytotoxicity] by the ongoing PRRSV infection was observed in dual-infected pigs, which coincided with exacerbated pneumonia during early PRCV infection. The subsequent PRCV infection led to enhanced PRRSV replication in the lungs and a trend towards increased serum T-helper type 1 (Th1) (IFN-gamma) but decreased Th2 [interleukin (IL)-4] responses, further exacerbating PRRSV pneumonia. Following PRCV infection, more severe PRRSV-related pulmonary alveolar macrophage (PAM) apoptosis occurred, as determined by an in situ terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling assay, suggesting increased PRRSV replication in PAMs. Collectively, these observations suggest interactive effects between PRCV and PRRSV via early innate (IFN-alpha) and later adaptive Th1 (IFN-gamma) and Th2 (IL-4) immune responses. These findings imply that an existing immunomodulating respiratory viral co-infection may be a contributing factor to more severe pneumonia in respiratory CoV disease. This study provides new insights into host-pathogen interactions related to co-infection by CoVs and other respiratory viruses.

Entities:  

Mesh:

Year:  2009        PMID: 19656969      PMCID: PMC2862479          DOI: 10.1099/vir.0.014001-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  40 in total

1.  2000 Report of the AVMA Panel on Euthanasia.

Authors: 
Journal:  J Am Vet Med Assoc       Date:  2001-03-01       Impact factor: 1.936

Review 2.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

Review 3.  Porcine reproductive and respiratory syndrome.

Authors:  K D Rossow
Journal:  Vet Pathol       Date:  1998-01       Impact factor: 2.221

4.  Human immunopathogenesis of severe acute respiratory syndrome (SARS).

Authors:  Mark J Cameron; Jesus F Bermejo-Martin; Ali Danesh; Matthew P Muller; David J Kelvin
Journal:  Virus Res       Date:  2007-03-19       Impact factor: 3.303

5.  An interferon-gamma-related cytokine storm in SARS patients.

Authors:  Kao-Jean Huang; Ih-Jen Su; Michel Theron; Yi-Chun Wu; Shu-Kuan Lai; Ching-Chuan Liu; Huan-Yao Lei
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

6.  Pulmonary pathology of severe acute respiratory syndrome in Toronto.

Authors:  David M Hwang; Dean W Chamberlain; Susan M Poutanen; Donald E Low; Sylvia L Asa; Jagdish Butany
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

7.  Impact of porcine group A rotavirus co-infection on porcine epidemic diarrhea virus pathogenicity in piglets.

Authors:  Kwonil Jung; Bo-Kyu Kang; Chul-Seung Lee; Dae-Sub Song
Journal:  Res Vet Sci       Date:  2007-08-28       Impact factor: 2.534

8.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Authors:  Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

9.  Pathogenicity of concurrent infection of pigs with porcine respiratory coronavirus and swine influenza virus.

Authors:  I Lanza; I H Brown; D J Paton
Journal:  Res Vet Sci       Date:  1992-11       Impact factor: 2.534

Review 10.  The challenge of PRRS immunology.

Authors:  E Mateu; I Diaz
Journal:  Vet J       Date:  2007-07-20       Impact factor: 2.688

View more
  52 in total

1.  Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: a potential animal model.

Authors:  Gourapura J Renukaradhya; Cordelia Manickam; Mahesh Khatri; Abdul Rauf; Xiangming Li; Moriya Tsuji; Gireesh Rajashekara; Varun Dwivedi
Journal:  J Clin Immunol       Date:  2010-11-02       Impact factor: 8.317

2.  Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.

Authors:  Andres J Gonzalez; Emmanuel C Ijezie; Onesmo B Balemba; Tanya A Miura
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

3.  Therapeutic potential of porcine bronchoalveolar fluid-derived mesenchymal stromal cells in a pig model of LPS-induced ALI.

Authors:  Mahesh Khatri; Levi A Richardson
Journal:  J Cell Physiol       Date:  2018-01-19       Impact factor: 6.384

4.  Expanded cocirculation of stable subtypes, emerging lineages, and new sporadic reassortants of porcine influenza viruses in swine populations in Northwest Germany.

Authors:  Timm C Harder; Elisabeth Grosse Beilage; Elke Lange; Carolin Meiners; Stefanie Döhring; Stefan Pesch; Thomas Noé; Christian Grund; Martin Beer; Elke Starick
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

5.  Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs.

Authors:  Gourapura J Renukaradhya; Konstantin Alekseev; Kwonil Jung; Ying Fang; Linda J Saif
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

6.  Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus.

Authors:  Mahesh Khatri; Varun Dwivedi; Steven Krakowka; Cordelia Manickam; Ahmed Ali; Leyi Wang; Zhuoming Qin; Gourapura J Renukaradhya; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

7.  Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus.

Authors:  Kwonil Jung; Ashita Gurnani; Gourapura J Renukaradhya; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2010-04-01       Impact factor: 2.046

8.  Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs.

Authors:  Cordelia Manickam; Varun Dwivedi; Jayla Miller; Tracey Papenfuss; Gourapura J Renukaradhya
Journal:  Viral Immunol       Date:  2013-01-11       Impact factor: 2.257

9.  Targeting Swine Leukocyte Antigen Class I Molecules for Proteasomal Degradation by the nsp1α Replicase Protein of the Chinese Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Strain JXwn06.

Authors:  Jige Du; Xinna Ge; Ying Liu; Ping Jiang; Zhe Wang; Ruimin Zhang; Lei Zhou; Xin Guo; Jun Han; Hanchun Yang
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals.

Authors:  Kwonil Jung; Qiuhong Wang; Yunjeong Kim; Kelly Scheuer; Zhenwen Zhang; Quan Shen; Kyeong-Ok Chang; Linda J Saif
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.